About Index Trending news
Lists
Pricing
ImaginAb

ImaginAb

ImaginAb

ImaginAb clinically manages cancer and autoimmune diseases via molecular imagingby re-engineering antibodies into small proteins.

Elsewhere

Contributors to this profile

Alexa global traffic share

12 Apr 2016
$5,340,000
Venture capital

SEC FORM D

sec
08 May 2014
$21,000,000
Venture capital (Series B)
27 Mar 2012
$12,500,000
Venture capital (Series A)
Cycad Group, Novartis Venture Fund, Momentum Bioscience